Analgesic effects of saikosaponin A in a rat model of chronic inflammatory pain

Nat Prod Res. 2023 Aug-Sep;37(16):2732-2736. doi: 10.1080/14786419.2022.2124985. Epub 2022 Sep 19.

Abstract

Saikosaponin A (SSA) is the main active ingredient of roots of the East Asian medicinal plant, Bupleurum falcatum L. The present study was aimed at delving into the analgesic properties of SSA in a model of chronic inflammatory pain. To this end, rats were initially treated intraplantarly with complete Freund's adjuvant for induction of hyperalgesia. Twenty-four hours later, rats were acutely treated with SSA (0, 1 and 2 mg/kg, i.p.) and exposed to the Von Frey monofilament test or Randall-Selitto paw pressure test for assessment of mechanical hyperalgesia. Treatment with 2 mg/kg SSA had analgesic effects: the nocifensive reaction (paw withdrawal) occurred later and required application of the nociceptive stimulus at a stronger pressure. The analgesic effects of SSA were of magnitude comparable to that of the effects exerted by the reference compound, acetyl salicylic acid (100 mg/kg, i.p.). The well-described anti-inflammatory properties of SSA likely underlie its analgesic effects.

Keywords: Bupleurum falcatum L; Randall-Selitto paw pressure test; Saikosaponin A; Von Frey monofilament test; chronic inflammatory pain; complete Freund’s adjuvant; rat.